Real-time evaluation of the deployment of connected technologies and the partnership of care and services in the context of the health crisis linked to COVID-19 - the Techno-COVID-Partnership program

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:239 publications

Grant number: Unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $376,865.25
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    N/A

  • Research Location

    Canada
  • Lead Research Institution

    Centre hospitalier de l'Université de Montréal
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    Digital Health

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Google translate: Faced with an unprecedented health crisis, the two establishments that receive the most patients with COVID-19 in Quebec have decided to implement social and technological innovations adapted to each stage of the trajectory of patients with COVID-19. COVID-19, from diagnosis to cure, in order to reduce isolation, maintain the partnership between patients and clinicians and promote the quality and safety of care. Grouped within the Techno-COVID-Partnership project, this research makes it possible to evaluate in real care situations, how these innovations are implemented, on what dimensions they act and how much they can cost as well as to determine if factors can explain certain results. The innovations studied relate to (i) the contribution of mobile applications for maintaining newly diagnosed patients; (ii) the combination of telephone calls from volunteers to break the isolation and the use of different technologies to carry out teleconsultations and remote monitoring; (iii) the adoption of a companion robot to entertain and care for COVID-19 patients hospitalized with psychiatric disorders; and (iv) support for patients during their transition and return home through COVID-19 support patients and a remote monitoring platform. The evaluation of these innovations is a unique opportunity to show how virtual health tools can potentially reliably treat thousands of patients over a short period of time while preserving health personnel at risk and ensuring the maintenance of social ties and the partnership. If the results are conclusive, they will make it possible to accelerate their implementation in other establishments (Canadian and international), not only for COVID-19 but also for any other health problem that can benefit from these technologies and modalities.]

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Development and Validation of the Intimate Partner Violence Workplace Disruptions Assessment (IPV-WDA).

Elucidating directed neural dynamics of scene construction across memory and imagination

Implementing a Novel Resident-Led Peer Support Program for Emergency Medicine Resident Physicians.

Cross-Activity Analysis of CRISPR/Cas9 Editing in Gene Families of <i>Solanum lycopersicum</i> Detected by Long-Read Sequencing.

Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership.

A Comparison of Clinical Diagnostic Classification Criteria Used in Longitudinal Cohort Studies of the Alzheimer's Disease Continuum: A Systematic Review.

Identification and Characterization of a Rare Exon 22 Duplication in <i>CFTR</i> in Two Families.

Structural Rearrangement in Cyclic Cu(II) Pyridyltriazole Complexes: Oxidation of Dabco to Oxalate and CO<sub>2</sub> Conversion to Carbonate.

Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.